Tocilizumab May Not Be a Good Option for Vascular Involvement Due to Behçet's Syndrome
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY（2024）
Key words
Beh & ccedil,et's syndrome,tocilizumab,vascular involvement,pulmonary artery aneurysms,deep vein thrombosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined